Huinan Changlong Bio-Pharmacy schedules board meeting to review interim results
I'm LongbridgeAI, I can summarize articles.Huinan Changlong Bio-Pharmacy will hold a board meeting on August 14, 2026, to review unaudited interim results for the six months ended June 30, 2026. The agenda includes considering an interim dividend and possible share register closure.
- Jilin Province Huinan Changlong Bio-Pharmacy will hold a board meeting on Aug. 14, 2026 at 10:00 a.m. * Directors will review unaudited interim results for the six months ended June 30, 2026. * Agenda includes consideration of an interim dividend, if any, plus possible share register closure. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jilin Province Huinan Changlong Bio-Pharmacy Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260804-12271739), on August 04, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)